Solar energy manufacturer SunPower (SPWR) continued its revenue slide late Tuesday when it reported its third straight sequential decline, with sales plummeting 39% from the year-earlier quarter, its biggest percentage decline since Q4 2011. The revenue drop comes five months after No. 2 solar panel maker SunPower partnered with No. 1 First Solar (FSLR) to create 8point3 Energy Partners (CAFD), a yield company, or yieldco. The IPO prospectus for
Akamai Technologies reported Q2 profit that missed views amid network investments tied to the delayed launch of Web TV services by Apple, sending its stock down late Tuesday. Akamai’s (AKAM) current quarter EPS and revenue guidance also fell short of expectations. Akamai’s stock fell 11% in after-hours trading. Cambridge, Mass.-based Akamai said it earned 57 cents per share in the June quarter, down 2% from a year earlier, and a penny light of
Big biotech Gilead Sciences handily beat analysts’ Q2 estimates and raised its full-year guidance Tuesday afternoon, led by sales of its blockbuster hepatitis C drugs. Earnings, excluding one-time items, rose 33.5% over the year-earlier quarter to $3.15 a share, beating analysts’ consensus by 44 cents, according to Thomson Reuters. Revenue climbed 26% to $8.24 billion, some $800 million above the Street’s number. Gilead (GILD) duly